Keyphrases
Schizophrenia
86%
Alzheimer's Disease
83%
Posttraumatic Stress Disorder
42%
Major Depressive Disorder
33%
Bipolar Disorder
32%
Autism Spectrum Disorder
29%
Attention Deficit Hyperactivity Disorder
23%
Autism
20%
Schizophrenic Patients
20%
Nucleus Accumbens
18%
Psychiatric Disorders
18%
Antidepressants
16%
Cognitive Impairment
15%
Brain Regions
15%
Genome-wide Association Study
15%
Obsessive-compulsive Disorder
15%
Psychosis
15%
Dementia
15%
Gene Expression
14%
Meta-analysis
14%
Healthy Controls
14%
Patients with Schizophrenia
13%
Neuropathology
13%
Resilience
13%
Prefrontal Cortex
13%
Cocaine
13%
Borderline Personality Disorder
13%
Placebo
12%
Hippocampus
12%
Human Brain
12%
Functional Magnetic Resonance Imaging
12%
Risk Factors
12%
Older Adults
11%
Depressive Symptoms
10%
COVID-19
10%
Addiction
10%
Suicide
9%
Anxiety Disorders
9%
Neurofibrillary Tangles
9%
Schizotypal Personality Disorder
9%
Amygdala
9%
Electroconvulsive Therapy
9%
Alzheimer
9%
Personality Disorders
8%
Mood Disorders
8%
Illness
8%
Ketamine
8%
Aging
8%
Cognitive Function
8%
Antipsychotics
8%
Comorbidity
8%
Alzheimer's Disease Pathology
8%
Psychiatry
8%
Neurodegenerative Diseases
8%
Schizophrenia Symptoms
8%
Anterior Cingulate Cortex
8%
Induced Pluripotent Stem Cells (iPSCs)
8%
Psychopathology
8%
Amyloid Precursor Protein
8%
Suicidal Behavior
8%
Neurobiology
8%
Genetic Risk
7%
Cognitive Decline
7%
Mental Health
7%
COVID-19 Pandemic
7%
Single nucleotide Polymorphism
7%
Confidence Interval
7%
Microglia
7%
Substance Use Disorder
7%
Suicidal Ideation
7%
New York City
7%
Striatal
7%
Randomized Controlled Trial
7%
Eating Disorders
7%
Deep Brain Stimulation
7%
Treatment-resistant Depression
7%
Clinical Trials
7%
United States
7%
Neurodevelopmental Disorders
7%
Vulnerability
7%
Cerebrospinal Fluid
7%
Aggression
7%
Dopamine
7%
Genotype
7%
Pathophysiology
6%
Neurodegeneration
6%
Etiology
6%
Control Subjects
6%
Medial Prefrontal Cortex (mPFC)
6%
Parkinson's Disease
6%
Presenilin
6%
Schizophrenia Spectrum Disorders
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Comorbid
6%
Symptom Severity
6%
Trauma
6%
Clinical High Risk for Psychosis (CHR-P)
6%
Caregivers
6%
Cerebral Cortex
6%
Anorexia Nervosa
6%
Neuroscience
Dementia Praecox
100%
Alzheimer's Disease
75%
Behavior (Neuroscience)
41%
Posttraumatic Stress Disorder
36%
Pervasive Developmental Disorder
36%
Major Depressive Disorder
32%
Bipolar Disorder
28%
Gene Expression
23%
Cognitive Disorders
23%
Prefrontal Cortex
20%
Antidepressant
19%
Nucleus Accumbens
18%
Attention Deficit Hyperactivity Disorder
17%
Hippocampus
17%
Functional Magnetic Resonance Imaging
14%
Placebo
14%
Physical Dependence
14%
Amyloid
13%
Amygdala
12%
Eicosanoid Receptor
12%
Obsessive-Compulsive Disorder
12%
Cognitive Function
12%
Meta-Analysis
12%
Mood Disorder
11%
Genome-Wide Association Study
11%
Cortisol
10%
In Vivo
10%
Metabolic Pathway
10%
Frontal Lobe
10%
Psychosis
9%
Borderline Personality Disorder
9%
Magnetic Resonance Imaging
8%
Gray Matter
8%
Serotonin
8%
Schizotypal Personality Disorder
8%
Neurodegenerative Disorder
8%
Psychiatry
8%
Synapse
8%
Opiate
8%
Ketamine
8%
Positron Emission Tomography
8%
Cerebral Cortex
8%
Depression
8%
Single-Nucleotide Polymorphism
8%
Neuroscience
7%
Anxiety Disorder
7%
Thalamus
7%
Anterior Cingulate Cortex
7%
Amyloid Precursor Protein
7%
Magnetic Resonance Imaging
7%
Typical Antipsychotic
7%
Working Memory
7%
Neuroscience
7%
Electrical Brain Stimulation
7%
Parkinson's Disease
7%
Temporal Lobe
7%
Personality Disorder
7%
Epileptic Absence
7%
Functional Connectivity
6%
Encephalopathy
6%
Microglia
6%
Glutamic Acid
6%
Neurodegeneration
6%
In Vitro
6%
Striatum
6%
Cannabis
6%
Substance Abuse
6%
Transcriptomics
6%
Social Defeat
6%
Antipsychotic
6%
Ventral Tegmental Area
6%
Treatment-Resistant Depression
6%
Central Nervous System
6%
Promoter Region
6%
Mental Disorder
5%
Negative Syndrome
5%
Astrocyte
5%
Oligodendrocyte
5%
Stem Cell
5%
Morphine
5%
Transcriptome
5%
Brain-Derived Neurotrophic Factor
5%
Neurotrauma
5%
Impulsivity
5%
Traumatic Brain Injury
5%
Brain Function
5%
Cell Signaling
5%
Serotonergic
5%
δ -Opioid Receptor
5%
Electroconvulsive Therapy
5%
Neurotransmitter
5%
Visual Cortex
5%
Eating Disorder
5%
Dopaminergic
5%
Tauopathy
5%
Dorsolateral Prefrontal Cortex
5%
Fractional Anisotropy
5%
Mild Cognitive Impairment
5%